Department of Surgery Grand Rounds

"Shaping The Future of Surgery:

Inspiring the Next Generation Through Surgical Education.”

Mahnoor Zia, MD

Surgery Resident PGY-5, Department of Surgery

Houston Methodist Hospital

STATEMENT OF NEED

 Houston Methodist Department of Surgery Grand Rounds provides an environment for the review and discussion of institutional quality and national quality metrics programs. It will meet the ongoing educational needs of members of the surgical and medical staff in advances in surgical patient care management and elements in the professional and socioeconomic environment of surgical care delivery.

TARGET AUDIENCE

This course is designed for attending surgeons, physicians, allied health personnel, residents, and medical students affiliated with Houston Methodist Hospital or other institutions.

EDUCATIONAL OBJECTIVES

At the conclusion of this activity, the participant should be able to:

• Recognize challenges impacting recruitment into surgical careers
• Understand how education and mentorship influence career choices
• Identify strategies to inspire and develop future surgeons

Course Director: A. Osama Gaber, MD, FACS, FAST

ACCREDITATION AND CREDIT DESIGNATION STATEMENTS

Houston Methodist is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Houston Methodist designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Successful completion of this CME activity enables the learner to earn credit toward the CME requirement(s) of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

FACULTY DISCLOSURES

Houston Methodist makes every effort to develop continuing education activities that are scientifically based, accurate, current, and objectively presented. In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education and American Nurse Credentialing Center (ANCC) and Accreditation Council for Pharmacy Education (ACPE) guidelines, Houston Methodist has implemented a mechanism requiring everyone in a position to control content of an educational activity (e.g., directors, planning committee members, contributors, peer reviewers,  etc.) to disclose all financial relationships with ineligible companies (companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients) and mitigate any relevant financial relationships prior to the activity. Individuals must disclose to participants the existence of financial relationships at the time of the activity and 24 months prior.

Houston Methodist does not view the existence of interests or relationships with ineligible companies as implying bias or decreasing the value of a presentation. It is up to the participants to determine whether the interests or relationships influence the presenter with regard to exposition or conclusions.

In addition, if contributors will be discussing products (drugs/devices) they have been instructed to use generic names and to include various products within and across classes. If at any time during this activity you feel that there has been commercial or promotional bias, please notify the CE coordinator for the activity and note your comments by using the commercial bias comments box in the evaluation form. Please answer the question about balance in the CE activity evaluation candidly.

Some drugs/devices identified during this activity may have United States Food and Drug Administration (FDA) clearance for specific purposes only or for use in restricted research settings. The FDA has stated that it is the responsibility of the individual physician to determine the FDA status of each drug or device that he/she wishes to use in clinical practice and to use the products in compliance with applicable law.

Faculty members are also asked to disclose any unlabeled use or investigational use (not yet approved for any purpose) or pharmaceutical and medical device products and provide adequate scientific and clinical justification for such use. Physicians are urged to fully review all the available data on products or procedures before using them to treat patients.

Everyone in control of content for this activity has no relevant financial relationships with ineligible companies to disclose.